Optimization and biodistribution of [11C]-TKF, an analog of tau protein imaging agent [18F]-THK523

Molecules

Volumn 21, Issue 8, 2016, Pages

  Kong, Yanyan ^a   Guan, Yihui ^a   Hua, Fengchun ^a   Zhang, Zhengwei ^a   Lu, Xiuhong ^a   Zhu, Tengfang ^b   Zhao, Bizeng ^c   Zhu, Jianhua ^b   Li, Cong ^b   Chen, Jian ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Imaging; Neurofibrillary tangles (NFTs); Positron emission tomography (PET); Tau

Indexed keywords

CARBON; FLUORINE; RADIOPHARMACEUTICAL AGENT; TAU PROTEIN;

ANIMAL; BRAIN; C57BL MOUSE; CHEMISTRY; DIAGNOSTIC IMAGING; METABOLISM; MOUSE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; FLUORINE RADIOISOTOPES; MICE; MICE, INBRED C57BL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TAU PROTEINS; TISSUE DISTRIBUTION;

EID: 84983371645     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21081019     Document Type: Article

References (21)

1. Gilbert, B.J. The role of amyloid beta in the pathogenesis of Alzheimer's disease. Postgrad. Med. J. 2014, 90, 113-117.
2. Reddy, P.H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res. 2011, 1415, 136-148.
3. Iqbal, K.; Alonso, A.D.C.; Chen, S.; Chohan, M.O.; El-Akkad, E.; Gong, C.X.; Khatoon, S.; Li, B.; Liu, F.; Rahman, A.; et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 2005, 1739, 198-210.
4. Witman, G.B.; Cleveland, D.W.; Weingarten, M.D.; Kirschner, M.W. Tubulin requires tau for growth onto microtubule initiating sites. Proc. Natl. Acad. Sci. USA 1976, 73, 4070-4074.
5. De Calignon, A.; Polydoro, M.; Suarez-Calvet, M.; William, C.; Adamowicz, D.H.; Kopeikina, K.J.; Pitstick, R.; Sahara, N.; Ashe, K.H.; Carlson, G.A.; et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73, 685-697.
6. Arriagada, P.V.; Growdon, J.H.; Hedley-Whyte, E.T.; Hyman, B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992, 42, 631-639.
7. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. J. Nucl. Med. 2016, 57, 208-214.
8. 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment and Alzheimer's disease. J. Nucl. Med. 2016.
9. Rojo, L.E.; Alzate-Morales, J.; Saavedra, I.N.; Davies, P.; Maccioni, R.B. Selective interaction of lansoprazole and astemizole with tau polymers: Potential new clinical use in diagnosis of Alzheimer's disease. J. Alzheimers Dis. 2010, 19, 573-589.
10. Chien, D.T.; Bahri, S.; zardenings, A.K.; Walsh, J.C.; Mu, F.; Su, M.Y.; Shankle, W.R.; Elizarov, A.; Kolb, H.C. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J. Alzheimers Dis. 2013, 34, 457-468.
11. 18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Alzheimers Dement. 2013, 9, 666-676.
12. Zhang, W.; Arteaga, J.; Cashion, D.K.; Chen, G.; Gangadharmath, U.; Gomez, L.F.; Kasi, D.; Lam, C.; Liang, Q.; Liu, C.; et al. A highly selective and specific PET tracer for imaging of tau pathologies. J. Alzheimers Dis. 2012, 31, 601-612.
13. 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J. Nucl. Med. 2013, 54, 1420-1427.
14. Tago, T.; Furumoto, S.; Okamura, N.; Harada, R.; Ishikawa, Y.; Arai, H.; Yanai, K.; Iwata, R.; Kudo, Y. Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging. J. Label. Comp. Radiopharm. 2014, 57, 18-24.
15. Okamura, N.; Suemoto, T.; Furumoto, S.; Suzuki, M.; Shimadzu, H.; Akatsu, H.; Yamamoto, T.; Fujiwara, H.; Nemoto, M.; Maruyama, M.; et al. Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease. J Neurosci. 2005, 25, 10857-10862.
16. 18F-THK523: A novel in vivo tau imaging ligand for Alzheimer's disease. Brain 2011, 134, 1089-1100.
17. 18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology. Eur. J. Nucl. Med. Mol. Imaging 2013, 40, 125-132.
18. Villemagne, V.L.; Furumoto, S.; Fodero-Tavoletti, M.T.; Mulligan, R.S.; Hodges, J.; Harada, R.; Yates, P.; Piguet, O.; Pejoska, S.; Doré, V.; et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2014, 41, 816-826.
19. Fodero-Tavoletti, M.T.; Furumoto, S.; Taylor, L.; McLean, C.A.; Mulligan, R.S.; Birchall, I.; Harada, R.; Masters, C.L.; Yanai, K.; Kudo, Y.; et al. Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies. Alzheimers Res. Ther. 2014, 6.
20. 18F]-THK523, a PET imaging probe for Tau pathologies. Nucl. Sci. Technol. 2014, 25.
21. 18F]-THK523 for tau imaging. Nucl. Sci. Technol. 2014, 25.